Report on the Canadian experience of Research Ethics Boards (REBs) harmonisation and centralisation
Projects
CCTCC Research Ethics Board (REB) Accreditation Working Group (WG)
The CCTCC REB WG has released its Final Recommendations (FRs).
CCTCC and Health Canada have developed a joint public response to the FRs outlining the steps the two organizations can take to address the FRs.
CCTCC_HC_response_CCTCC-REB-WG-Final-Recommendations_January-2017_FinalLatest Case Studies
Clinical trials transparency in the Americas: the need to coordinate regulatory spheres
BMJ 2018; 362:k2493 Author/Presenter: Trudo Lemmens, professor and Scholl chair in health law and policy, and Carlos Herrera Vacaflor, researcher
Investment Case – “Clinical Trials – The Canadian Advantage” – 2018
The case for running clinical trials in Canada, advantages and information (English, pdf format) Author/Presenter: CCTCC
